Please ensure Javascript is enabled for purposes of website accessibility

Why Oscar Health Stock Was on Fire Thursday

By Eric Volkman – Sep 2, 2021 at 4:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A new analyst has a strongly bullish outlook on the company.

What happened

Oscar Health (OSCR -2.79%) was hardly a grouch of a stock on Thursday. The next-generation health insurance company's shares closed more than 16% higher on the day, thanks to a positive research note from a noted investment bank.

So what

Early Thursday morning, Credit Suisse analyst Jonathan Yong assumed coverage on Oscar Health stock. The prognosticator is quite bullish on the company's prospects, as he's tagged it with an outperform (i.e., buy) recommendation at a price target of $34 per share -- nearly double the stock's current level.

A medical professional in discussions with a colleague.

Image source: Getty Images.

That outlook matched that of Yong's predecessor, Jailendra Singh, who also flagged Oscar Health as an outperform worth $34 per share. Singh's prognostication was published in late March, several weeks after the health insurer's initial public offering.

The stock hasn't exactly lit the investing world on fire, having nosedived quickly and precipitously from its $36-per-share IPO price. While premiums and, especially, revenue have been on the upswing (as indicated by the company's recently reported second quarter), the company remains deeply in the red on the bottom line. In fact, its quarterly net loss deepened by over $32 million during the quarter, to just over $73 million.

Now what

It wasn't immediately apparent why Yong is continuing on Credit Suisse's bullish track for Oscar Health stock. The company -- a relatively very young player among established rivals in the health insurance industry -- certainly has potential, with its tech-based, customer service-focused approach. Perhaps with the investment bank reiterating its positive view on the shares, investors are starting to consider them a bargain just now.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Oscar Health, Inc. Stock Quote
Oscar Health, Inc.
OSCR
$2.79 (-2.79%) $0.08
Credit Suisse Group Stock Quote
Credit Suisse Group
CS
$3.37 (-6.13%) $0.22

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.